Orion OYJ (OTCMKTS:ORINY) Issues Earnings Results

Orion OYJ (OTCMKTS:ORINY) posted its quarterly earnings data on Friday. The company reported $0.58 EPS for the quarter, Zacks reports. Orion OYJ had a net margin of 27.14% and a return on equity of 49.17%.

Orion OYJ Stock Performance

Shares of ORINY stock opened at $38.54 on Friday. Orion OYJ has a one year low of $30.89 and a one year high of $42.75. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.13 and a current ratio of 1.77. The stock has a market capitalization of $10.88 billion, a price-to-earnings ratio of 17.68 and a beta of 0.08. The company’s 50-day simple moving average is $38.41 and its 200-day simple moving average is $38.72.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.